“Current evidence does not, therefore, appear to show a need for boosting in the general population, in which efficacy against severe disease remains high.”
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02046-8/fulltext
https://twitter.com/RealJoelSmalley/status/1438235797455609860?s=20
Considerations in boosting COVID-19 vaccine immune responses
Philip R Krause, MD
et al.
Show all authors
Published:September 13, 2021DOI: https://doi.org/10.1016/S0140-6736(21)02046-8
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02046-8/fulltext